Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,622 INKT shares, $17.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,622 | $17.8K |
| Jun 5, 2026 | MiNK Therapeutics, Inc. (INKT) | Sale | 500 | $6.3K |
| Jun 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,629 | $17.8K |
| May 14, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Grant/Award | 6,518 | n/a |
| Mar 13, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Purchase | 8 | $248.68 |
| Mar 11, 2026 | MiNK Therapeutics, Inc. (INKT) | Sale | 200 | $2.0K |
| Mar 11, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Purchase | 31 | $1.0K |
| Mar 4, 2026 | MiNK Therapeutics, Inc. (INKT) | Sale | 400 | $4.3K |
| Jan 28, 2026 | Indivior Pharmaceuticals, Inc. (INDV) | Grant/Award | 3,722 | n/a |
| Jan 7, 2026 | INDIVIOR PLC (INDV) | Purchase | 775 | $27.4K |